Nalaganje...
Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia: A Review of Tyrosine Kinase Inhibitors
Chronic myeloid leukemia (CML) is a progressive and often fatal myeloproliferative neoplasm. The hallmark of CML is an acquired chromosomal translocation known as the Philadelphia chromosome (Ph), which results in the synthesis of the breakpoint cluster region-Abelson murine leukemia (BCR-ABL) fusio...
Shranjeno v:
| izdano v: | Cancer |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4428165/ https://ncbi.nlm.nih.gov/pubmed/20945321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25656 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|